AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 170 filers reported holding AGIOS PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 1.15 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,143,500 | -7.0% | 46,202 | +6.4% | 0.14% | -14.8% |
| Q2 2023 | $1,229,371 | +104.1% | 43,410 | +65.6% | 0.17% | +106.1% |
| Q1 2023 | $602,204 | -66.3% | 26,217 | -58.8% | 0.08% | -71.6% |
| Q4 2022 | $1,786,590 | -13.2% | 63,625 | -12.6% | 0.29% | -7.1% |
| Q3 2022 | $2,058,000 | -20.4% | 72,778 | -37.5% | 0.31% | +36.4% |
| Q2 2022 | $2,584,000 | +175.2% | 116,532 | +261.1% | 0.23% | +181.5% |
| Q1 2022 | $939,000 | -74.6% | 32,274 | -55.0% | 0.08% | -69.5% |
| Q1 2021 | $3,703,000 | -24.1% | 71,700 | -36.3% | 0.27% | -19.4% |
| Q4 2020 | $4,878,000 | +31.1% | 112,578 | +5.9% | 0.33% | +34.1% |
| Q3 2020 | $3,721,000 | -9.6% | 106,300 | +38.1% | 0.25% | -12.1% |
| Q2 2020 | $4,118,000 | +25.5% | 77,000 | -16.7% | 0.28% | +7.7% |
| Q1 2020 | $3,280,000 | -27.9% | 92,434 | -3.0% | 0.26% | -7.5% |
| Q4 2019 | $4,552,000 | +92.2% | 95,332 | +30.4% | 0.28% | +99.3% |
| Q3 2019 | $2,368,000 | -35.1% | 73,100 | -0.0% | 0.14% | -34.7% |
| Q2 2019 | $3,647,000 | -34.6% | 73,121 | +10.5% | 0.22% | +1.9% |
| Q2 2018 | $5,576,000 | -38.0% | 66,200 | -39.8% | 0.21% | -30.3% |
| Q1 2018 | $8,999,000 | +4.1% | 110,036 | -27.3% | 0.30% | +21.1% |
| Q4 2017 | $8,648,000 | -30.4% | 151,268 | -18.7% | 0.25% | -38.9% |
| Q3 2017 | $12,422,000 | +29.9% | 186,101 | +0.1% | 0.41% | +6.8% |
| Q2 2017 | $9,565,000 | +605.9% | 185,900 | +868.2% | 0.38% | +1183.3% |
| Q3 2015 | $1,355,000 | -8.3% | 19,200 | +44.4% | 0.03% | -23.1% |
| Q2 2015 | $1,478,000 | +28.5% | 13,300 | +9.0% | 0.04% | +34.5% |
| Q1 2015 | $1,150,000 | -15.9% | 12,200 | 0.0% | 0.03% | -78.7% |
| Q4 2014 | $1,367,000 | +12.0% | 12,200 | -38.7% | 0.14% | +325.0% |
| Q3 2014 | $1,221,000 | – | 19,900 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Eagle Health Investments LP | 431,413 | $12,558,000 | 3.09% |
| Casdin Capital, LLC | 2,090,000 | $60,840,000 | 2.73% |
| Rock Springs Capital Management LP | 2,665,275 | $77,586,000 | 1.95% |
| Bellevue Group AG | 4,129,292 | $120,204,000 | 1.40% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 1,177,374 | $34,273,000 | 1.05% |
| Altium Capital Management LP | 66,196 | $1,927,000 | 0.64% |
| ArrowMark Colorado Holdings LLC | 1,295,948 | $37,725,000 | 0.33% |
| FARALLON CAPITAL MANAGEMENT LLC | 1,333,012 | $38,804,000 | 0.19% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 21,500 | $707,000 | 0.16% |
| Virtus ETF Advisers LLC | 11,541 | $336,000 | 0.15% |